Frequent readers of The Health Care Blog have probably noticed Xerox’s name around more and more often – we partner with THCB to provide content and cover events. Was it unexpected at first? Are you beginning to understand why Xerox is represented in an outlet where conversations are dedicated to discussing healthcare hot topics?
We hope so. This week, our CEO, Ursula Burns spoke at the World Health Care Congress, and I’m sure that some of the attendees were scratching their heads about that as well. To be clear for anyone still wondering, healthcare is a primary area of focus for Xerox. Today, Xerox touches the lives of nearly one in every three insured individuals in the U.S. as the largest provider to manage all documents and business process needs within healthcare organizations.
One of our priorities is to simplifying how work gets done for healthcare professionals now and in the future. We invest more that $50 million annually in healthcare R&D, allowing scientists at our company’s research centers around the world to advance healthcare innovation. At WHCC Burns showed a video that features two of the most interesting research projects we’re working on:
·Medication management: our researchers are developing “smart” medication packaging that will allow pharmacies to help patients manage their daily prescription regimen more easily. The system uses innovations in personalization, data collection and packaging to organize medication, provide individualized instruction and then track whether a patient adheres to the doctor’s orders.
·Predictive clinical analytics: Midas+ Live, Xerox’s cloud-based solution that actively monitors patient data, will soon have a new user interface that prevents potential emerging complications. Caregivers will view data about multiple patients from one central location, accessible on mobile devices including smartphones and tablets.
The healthcare industry is in a period of great transition and turmoil. Standing still is not an option. Xerox is striving to introduce solutions that make a difference for our customers’ leaders – allowing them to act boldly and strategically, embrace innovation and technology, and show a little impatience with the status quo. We’ve shared some ideas on how to make healthcare simpler – what else would you like to see?
This article brought to you by Xerox Corporation: http://xrx.sm/BF4 . Chad Harris is the senior vice president and group president of Healthcare Provider and Applications for Xerox.
Very good point John. We all have a serious responsibility in striking an appropriate balance between regulation and securing personal health information (PHI) while continuing to identify how to apply these new technologies in ways that make a meaningful impact to all stakeholders in the continuum of care…including the patient. Xerox along with the Palo Alto Research Center (PARC) have a long history of leading the industry in dealing with sensitive data while maintain the ability to utilize cutting edge technologies.
We have put a lot of thought into mobile application security – especially with the Midas+ Live application mentioned above. One of the challenges faced by Midas+ Live users is keeping up with the real time nature of the data. Most users are using desktop machines, but are typically highly mobile during their work day. Because of this, many users print their patient card view, then carry this around with them for most of the day. Therefore, the “real time” data flow does not make its way to the printed page. Security for the Midas+ Live mobile application is addressed from an inside-out perspective, meaning we start with securing the data itself, and then work our way out a layer at a time in adding security layers.
The use of smartphones and tablets to receive patient information presents some unique problems. First, the issue of data security. As more and more Americans begin to use smartphones and the healthcare industry delivers information to them, patient information will be less confidential. I’m thinking stolen, lost phones?
Second, is the regulatory environment on mHealth apps. Given the extent of information and uses of smartphones in patient treatment, it’s likely the FDA will have a significant impact on the market. Here’s a good short article on the subject:http://bit.ly/ynprju